11/23/2011 7:43:55 AM
The manufacturing problems engulfing the troubled Boehringer Ingelheim unit have just grown worse. The European Medicines Agency has just issued a ‘precautionary’ recall for the remaining batches of three cancer meds - Busilvex, Velcade and Vidaza - that were manufactured at its Ben Venue Laborartories facility in Ohio. And no new patients are to be treated with yet another med, Doxil. The move comes just four days Ben Venue disclosed plans to “voluntarily and temporarily” suspend production and distribution at its Bedford, Ohio, plant, and one month after reluctantly putting a halt to its contract manufacturing activities, exacerbating shortages of various life-saving meds for which alternate sources are not always available (read here).
comments powered by